Openn Negotiation Limited

OPN

Openn Negotiation Ltd. engages in buying and selling of real estate properties. The firm is an online auction and property sales platform. The firm offers a cloud-based software platform to support real estate agents in selling property online. The firm's primary business is the operation of the Platform, which enables the listing and sale of residential real estate online utilizing the Openn Negotiation Process. The business services the Australian and New Zealand residential property markets. Its Platform facilitates a negotiation process, featuring streamlined digital contracting and automated communication tools. Its solution provides buyers with real-time feedback through their device on how much competition exists and where their price stands in the negotiation, providing transparency to the sales transaction process. The firm offers Openn Offers to provide another real estate sales method, which follows a typical private treaty sales process.

Opthea Limited

OPT

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. The company is headquartered in Melbourne, Victoria. The firm is engaged in the development and commercialization of therapies primarily for eye disease. The Company’s lead asset, OPT-302, is a novel biologic inhibitor of VEGF-C and VEGF-D, for use in combination with VEGF-A inhibitors for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The Company’s principal activities include the progression of the Company’s Phase III registration trials of OPT-302 for wet AMD. The company also manufactures OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. The Company’s development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).

Optima Technology Group Ltd

OPA

Optima Technology Group Ltd. engages in the provision of cloud-based energy spend management platforms. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-01-27. The firm offers automated and secure energy data management solutions focused on Net Zero reporting as well as bill management and procurement planning. The firm collates and aggregates energy and utility invoices from multiple suppliers. The company also extracts data with audit-grade accuracy for easier bill management and reporting. The company creates engaging, bespoke reports on energy use and spending, set baselines and targets and tracks emissions to streamline sustainability performance to global reporting frameworks. The company also manages energy use, spending, budgeting, and forecasting on its platform.

Ophir High Conviction Fund

OPH

Ophir High Conviction Fund is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales and currently employs 0 full-time employees. The company went IPO on 2018-12-19. Ophir High Conviction Fund is an Australia-based small and mid-cap equities fund. The Fund’s investment objective is to invest in approximately 15-30 companies listed outside the S&P/Australian Securities Exchange (ASX) 50. The Fund may also invest in international equities, such as listed securities in New Zealand, in accordance with the product disclosure statement and the provisions of the Fund's Constitution. The company invests in various sectors, including communication services, consumer discretionary, consumer staples, energy, financials, health care, industrials, information technology, materials, real estate, and utilities. Ophir Asset Management Pty Ltd is the responsible entity and manager of the Company.